The cell therapy market size was valued USD 9.2 billion in 2021 and is projected to reach USD 26.9 Billion by 2030 at 9.3% CAGR during the assessment period 2022-2030, the autologous category is anticipated to command the market and have grown at a significant CAGR. A subspecialty of regenerative medicine is autologous cell treatment. Biologic cell-based therapies are used to treat a range of illnesses, including those with links to oncology, dermatology, and neurology, among others. Compared to allogeneic cell therapy, autologous cell therapy is anticipated to account for a sizable portion of the market.
The Americas region held the largest market share of 37.6% in 2017 and is expected to grow at a CAGR of 21.45% over the next five years. With the largest market share during the review period, North America is one of the region’s top markets.
Get FREE Sample Report @ https://www.marketresearchfuture.com/sample_request/5066
Regional Analysis:
The market for cell treatment has been divided geographically into North America, Europe, Asia-Pacific, and the rest of the globe. North America led the cell therapy market in 2017 and is predicted to continue to do so during the review period. During the forecast period, Europe is anticipated to be the second-largest market after North America. One of the main factors propelling the expansion of the cell therapy market in Europe is the rise in demand fo r cell therapy for the treatment of oncology. North America was the main driver of the market’s expansion, accounting for the largest market share in the Americas.
During the forecast period, the autologous segment is anticipated to have the highest CAGR, at 22.000%.
Market Segmentation:
The autologous and allogeneic segments of the global cell treatment market have been separated by type. Compared to allogeneic cell therapy, autologous cell therapy is predicted to hold a sizable market share. The global market for cell treatment has been segmented into consumables(vessel/media/serum/reagent), equipment, software, and other services based on product. The main reason that would probably fuel the growth of the consumables segment over the forecast period is the rising prevalence of infectious diseases.
The stem cell treatment, cell vaccine, adoptive cell transfer (act), fibroblast cell therapy, and chondrocyte cell therapy segments of the worldwide cell therapy market have been identified based on technique. The technologies that make up the worldwide cell treatment market include those for viral vectors, cell immortalization, and genome editing.The global cell treatment market has been segmented into bone marrow, adipose tissue, and umbilical cord blood-derived cells based on the source of the cells. Market expansion is anticipated to be fueled by the increased demand for bone marrow transplantation as a treatment for ischemic heart conditions.
The global cell therapy market has been segmented based on application into oncology, cardiovascular disease (CVD), orthopaedic, and wound healing. Additionally, the worldwide cell therapy market has been divided into hospital & clinics, regenerative medicine centres, and research institutes based on end user.
Key Players:
The major companies involved are Mesoblast Ltd, Vericel Corporation, Osiris Therapeutics, Inc., JCR Pharmaceuticals Co., Ltd., NuVasive, Pharmicell Co., RTI Surgical Holdings, AlloSource, Holostem Terapie Avanzate S.R.L. and Medipost Co.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/cell-therapy-market-5066
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Get More Report:
Cosmetic Surgery Market Research Report – Global Forecast till 2030
mHealth Applications Market Research Report – Global Forecast till 2030
Aromatherapy Market Research Report – Global Forecast till 2030